{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:40:35Z","timestamp":1787964035864,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000938","name":"Department of Veterans' Affairs, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40264-022-01238-4","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T03:23:01Z","timestamp":1663730581000},"page":"1413-1421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case\u2013Control Study with a Focus on Medicines Used in Primary Care"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6811-8991","authenticated-orcid":false,"given":"Elizabeth E.","family":"Roughead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8695-0693","authenticated-orcid":false,"given":"Mhairi","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-1564","authenticated-orcid":false,"given":"Anna","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-3771","authenticated-orcid":false,"given":"Gizat M.","family":"Kassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-8910","authenticated-orcid":false,"given":"Nicole","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"issue":"6","key":"1238_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2215\/CJN.07920713","volume":"9","author":"A Wonnacott","year":"2014","unstructured":"Wonnacott A, Meran S, Amphlett B, Talabani B, Phillips A. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI. Clin J Am Soc Nephrol. 2014;9(6):1007\u201314. https:\/\/doi.org\/10.2215\/CJN.07920713.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1238_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2215\/CJN.02730313","volume":"9","author":"X Zeng","year":"2014","unstructured":"Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9(1):12\u201320. https:\/\/doi.org\/10.2215\/CJN.02730313.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"1238_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411\u201323. https:\/\/doi.org\/10.1007\/s00134-015-3934-7.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1238_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13(4):241\u201357. https:\/\/doi.org\/10.1038\/nrneph.2017.2.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"1238_CR5","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00520-010-0978-7","volume":"189","author":"A Linder","year":"2014","unstructured":"Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH. Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med. 2014;189(9):1075\u201381. https:\/\/doi.org\/10.1007\/s00520-010-0978-7.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1238_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607\u201325. https:\/\/doi.org\/10.1038\/s41581-018-0052-0.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"1238_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.18553\/jmcp.2016.22.8.959","volume":"22","author":"ML Davis-Ajami","year":"2016","unstructured":"Davis-Ajami ML, Fink JC, Wu J. Nephrotoxic medication exposure in U.S. adults with predialysis chronic kidney disease: health services utilization and cost outcomes. J Manag Care Spec Pharm. 2016;22(8):959\u201368. https:\/\/doi.org\/10.18553\/jmcp.2016.22.8.959.","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"1238_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/jgs.14809","volume":"65","author":"M Dorks","year":"2017","unstructured":"Dorks M, Allers K, Schmiemann G, Herget-Rosenthal S, Hoffmann F. Inappropriate medication in non-hospitalized patients with renal insufficiency: a systematic review. J Am Geriatr Soc. 2017;65(4):853\u201362. https:\/\/doi.org\/10.1111\/jgs.14809.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1238_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1345\/aph.1Q633","volume":"46","author":"AJ Leendertse","year":"2012","unstructured":"Leendertse AJ, van Dijk EA, De Smet PA, Egberts TC, van den Bemt PM. Contribution of renal impairment to potentially preventable medication-related hospital admissions. Ann Pharmacother. 2012;46(5):625\u201333. https:\/\/doi.org\/10.1345\/aph.1Q633.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"1238_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s40266-017-0490-6","volume":"34","author":"N Parameswaran Nair","year":"2017","unstructured":"Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain CM, Bereznicki LR. Repeat adverse drug reaction-related hospital admissions in elderly Australians: a retrospective study at the royal Hobart hospital. Drugs Aging. 2017;34(10):777\u201383. https:\/\/doi.org\/10.1007\/s40266-017-0490-6.","journal-title":"Drugs Aging"},{"issue":"4","key":"1238_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40264-022-01173-4","volume":"45","author":"MP Gray","year":"2022","unstructured":"Gray MP, Barreto EF, Schreier DJ, Kellum JA, Suh K, Kashani KB, et al. Consensus obtained for the nephrotoxic potential of 167 drugs in adult critically ill patients using a modified Delphi method. Drug Saf. 2022;45(4):389\u201398. https:\/\/doi.org\/10.1007\/s40264-022-01173-4.","journal-title":"Drug Saf"},{"issue":"8","key":"1238_CR12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH. Drug-induced acute kidney injury. Clin J Am Soc Nephrol. 2022;17(8):1220\u201333. https:\/\/doi.org\/10.2215\/CJN.11290821.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1238_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/01.ccx.0000184300.68383.95","volume":"11","author":"M Schetz","year":"2005","unstructured":"Schetz M, Dasta J, Goldstein S, Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care. 2005;11(6):555\u201365. https:\/\/doi.org\/10.1097\/01.ccx.0000184300.68383.95.","journal-title":"Curr Opin Crit Care"},{"key":"1238_CR14","first-page":"970","volume":"51","author":"NP Singh","year":"2003","unstructured":"Singh NP, Ganguli A, Prakash A. Drug-induced kidney diseases. J Assoc Physicians India. 2003;51:970\u20139.","journal-title":"J Assoc Physicians India"},{"issue":"10","key":"1238_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40266-017-0484-4","volume":"34","author":"S Khan","year":"2017","unstructured":"Khan S, Loi V, Rosner MH. Drug-induced kidney injury in the elderly. Drugs Aging. 2017;34(10):729\u201341. https:\/\/doi.org\/10.1007\/s40266-017-0484-4.","journal-title":"Drugs Aging"},{"issue":"1","key":"1238_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/his.13064","volume":"70","author":"P Paueksakon","year":"2017","unstructured":"Paueksakon P, Fogo AB. Drug-induced nephropathies. Histopathology. 2017;70(1):94\u2013108. https:\/\/doi.org\/10.1111\/his.13064.","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"1238_CR17","doi-asserted-by":"publisher","first-page":"s82","DOI":"10.1590\/1806-9282.66.S1.82","volume":"66","author":"GTM Sales","year":"2020","unstructured":"Sales GTM, Foresto RD. Drug-induced nephrotoxicity. Rev Assoc Med Bras (1992). 2020;66(Suppl 1):s82\u201390. https:\/\/doi.org\/10.1590\/1806-9282.66.S1.82.","journal-title":"Rev Assoc Med Bras (1992)."},{"issue":"3","key":"1238_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.12861\/jrip.2015.12","volume":"4","author":"F Ghane Shahrbaf","year":"2015","unstructured":"Ghane Shahrbaf F, Assadi F. Drug-induced renal disorders. J Renal Inj Prev. 2015;4(3):57\u201360. https:\/\/doi.org\/10.12861\/jrip.2015.12.","journal-title":"J Renal Inj Prev"},{"issue":"1","key":"1238_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/jcpt.12748","volume":"44","author":"K Hosohata","year":"2019","unstructured":"Hosohata K, Inada A, Oyama S, Furushima D, Yamada H, Iwanaga K. Surveillance of drugs that most frequently induce acute kidney injury: a pharmacovigilance approach. J Clin Pharm Ther. 2019;44(1):49\u201353. https:\/\/doi.org\/10.1111\/jcpt.12748.","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"1238_CR20","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/bcp.13216","volume":"83","author":"M Pierson-Marchandise","year":"2017","unstructured":"Pierson-Marchandise M, Gras V, Moragny J, Micallef J, Gaboriau L, Picard S, et al. The drugs that mostly frequently induce acute kidney injury: a case\u2013noncase study of a pharmacovigilance database. Br J Clin Pharmacol. 2017;83(6):1341\u20139. https:\/\/doi.org\/10.1111\/bcp.13216.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1238_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/phar.2152","volume":"38","author":"HK Welch","year":"2018","unstructured":"Welch HK, Kellum JA, Kane-Gill SL. Drug-associated acute kidney injury identified in the United States food and drug administration adverse event reporting system database. Pharmacotherapy. 2018;38(8):785\u201393. https:\/\/doi.org\/10.1002\/phar.2152.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"1238_CR22","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/MLR.0b013e31825f63bf","volume":"50","author":"MJ Schuemie","year":"2012","unstructured":"Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifiro G, Matthews JN, et al. Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care. 2012;50(10):890\u20137. https:\/\/doi.org\/10.1097\/MLR.0b013e31825f63bf.","journal-title":"Med Care"},{"issue":"6","key":"1238_CR23","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/14740338.2017.1325463","volume":"16","author":"M Arnaud","year":"2017","unstructured":"Arnaud M, Begaud B, Thurin N, Moore N, Pariente A, Salvo F. Methods for safety signal detection in healthcare databases: a literature review. Expert Opin Drug Saf. 2017;16(6):721\u201332. https:\/\/doi.org\/10.1080\/14740338.2017.1325463.","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl 1","key":"1238_CR24","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1007\/s40264-013-0108-9","volume":"36","author":"PB Ryan","year":"2013","unstructured":"Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, et al. A comparison of the empirical performance of methods for a risk identification system. Drug Saf. 2013;36(Suppl 1):S143\u201358. https:\/\/doi.org\/10.1007\/s40264-013-0108-9.","journal-title":"Drug Saf"},{"key":"1238_CR25","volume-title":"Primer on disproportionality analysis version: 2018\u201310-16","author":"R B\u00f6hm","year":"2018","unstructured":"B\u00f6hm R. Primer on disproportionality analysis version: 2018\u201310-16. Kiel: Kiel University; 2018."},{"key":"1238_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001821","author":"YJ Hwang","year":"2012","unstructured":"Hwang YJ, Shariff SZ, Gandhi S, Wald R, Clark E, Fleet JL, et al. Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admission. BMJ Open. 2012. https:\/\/doi.org\/10.1136\/bmjopen-2012-001821.","journal-title":"BMJ Open"},{"issue":"3","key":"1238_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/imj.13729","volume":"48","author":"S Ko","year":"2018","unstructured":"Ko S, Venkatesan S, Nand K, Levidiotis V, Nelson C, Janus E. International statistical classification of diseases and related health problems coding underestimates the incidence and prevalence of acute kidney injury and chronic kidney disease in general medical patients. Intern Med J. 2018;48(3):310\u20135. https:\/\/doi.org\/10.1111\/imj.13729.","journal-title":"Intern Med J"},{"issue":"5","key":"1238_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pds.3417","volume":"22","author":"IA Wahab","year":"2013","unstructured":"Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf. 2013;22(5):496\u2013502. https:\/\/doi.org\/10.1002\/pds.3417.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1238_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","volume":"32","author":"ECC Lai","year":"2017","unstructured":"Lai ECC, Pratt N, Hsieh CY, Lin SJ, Pottegard A, Roughead EE, et al. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. Eur J Epidemiol. 2017;32(7):567\u201382. https:\/\/doi.org\/10.1007\/s10654-017-0281-8.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"1238_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.1736","volume":"18","author":"I Tsiropoulos","year":"2009","unstructured":"Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidem Drug Saf. 2009;18(6):483\u201391. https:\/\/doi.org\/10.1002\/pds.1736.","journal-title":"Pharmacoepidem Drug Saf."},{"issue":"2","key":"1238_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/archinternmed.2011.1029","volume":"172","author":"SR Garrison","year":"2012","unstructured":"Garrison SR, Dormuth CR, Morrow RL, Carney GA, Khan KM. Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis. Arch Intern Med. 2012;172(2):120\u20136. https:\/\/doi.org\/10.1001\/archinternmed.2011.1029.","journal-title":"Arch Intern Med"},{"issue":"12","key":"1238_CR32","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s40264-017-0579-1","volume":"40","author":"AM Tomlin","year":"2017","unstructured":"Tomlin AM, Reith DM, Woods DJ, Lloyd HS, Smith A, Fountain JS, et al. A pharmacoepidemiology database system for monitoring risk due to the use of medicines by New Zealand primary care patients. Drug Saf. 2017;40(12):1259\u201377. https:\/\/doi.org\/10.1007\/s40264-017-0579-1.","journal-title":"Drug Saf"},{"key":"1238_CR33","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.2147\/CIA.S217567","volume":"14","author":"L Robert","year":"2019","unstructured":"Robert L, Ficheur G, Gautier S, Servais A, Luyckx M, Soula J, et al. Community-acquired acute kidney injury induced by drugs in older patients: a multifactorial event. Clin Interv Aging. 2019;14:2105\u201313. https:\/\/doi.org\/10.2147\/CIA.S217567.","journal-title":"Clin Interv Aging"},{"issue":"6","key":"1238_CR34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1159\/000506502","volume":"49","author":"JE Cely","year":"2020","unstructured":"Cely JE, Mendoza EJ, Sprockel JJ, Perez LC, Mateus JM, Maldonado S, et al. Risk factors for community-acquired acute kidney injury in medical patients: a nested case-control study. Blood Purif. 2020;49(6):677\u201384. https:\/\/doi.org\/10.1159\/000506502.","journal-title":"Blood Purif"},{"issue":"3","key":"1238_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1185\/03007995.2015.1010036","volume":"31","author":"HK Doody","year":"2015","unstructured":"Doody HK, Peterson GM, Watson D, Castelino RL. Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment. Curr Med Res Opin. 2015;31(3):525\u201335. https:\/\/doi.org\/10.1185\/03007995.2015.1010036.","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 2","key":"1238_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.2042-7174.2011.00147_1.x","volume":"19","author":"S Wood","year":"2011","unstructured":"Wood S, Petty D, Glidewell L, Raynor T. Are we over-dosing our elderly patients with renally excreted drugs in primary care? Int J Pharmacy Pract. 2011;19(Suppl 2):38. https:\/\/doi.org\/10.1111\/j.2042-7174.2011.00147_1.x.","journal-title":"Int J Pharmacy Pract."},{"issue":"670","key":"1238_CR37","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.3399\/bjgp18X695993","volume":"68","author":"S Wood","year":"2018","unstructured":"Wood S, Petty D, Glidewell L, Raynor DT. Application of prescribing recommendations in older people with reduced kidney function: a cross-sectional study in general practice. Br J Gen Pract. 2018;68(670):e378\u201387. https:\/\/doi.org\/10.3399\/bjgp18X695993.","journal-title":"Br J Gen Pract"},{"key":"1238_CR38","volume-title":"Guidelines for medicines optimisation in patients with acute kidney injury","author":"UK Renal Registry","year":"2016","unstructured":"UK Renal Registry. Guidelines for medicines optimisation in patients with acute kidney injury. London: UK Renal Registry; 2016."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01238-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-022-01238-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01238-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T20:52:48Z","timestamp":1668804768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-022-01238-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1007\/s40264-022-01238-4","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"4 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. This research was funded by the Australian Government Department of Veterans\u2019 Affairs as part of the Veterans Medicines Advice and Therapeutics Education Services (MATES) Program. The Australian Government Department of Veterans\u2019 Affairs reviewed the manuscript prior to submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Elizabeth E. Roughead, Mhairi Kerr, Anna Moffat, Gizat M. Kassie and Nicole Pratt have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"This research was approved by the University of South Australia Human Research Ethics Committee (P203-04) and the Departments of Defence and Veterans\u2019 Affairs Human Research Ethics Committee (E016-007).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Australian Government Department of Veterans\u2019 Affairs are the owners of the data. Requests for data would need to be made directly to the Australian Government Department of Veterans\u2019 Affairs","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The code created for this analysis is available on request to the authors.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"ER conceived and designed the research, interpreted the results, and drafted and finalised the manuscript. NP designed the research, interpreted the results, and critically reviewed the manuscript. MK contributed to the study design, created all study code, undertook all analyses, and assisted with data interpretation and manuscript review. AM contributed to data interpretation and synthesis, as well as manuscript development and review. GK contributed to data interpretation and synthesis, as well as manuscript development and review. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}